Encompass Health Corp — Form 8-K
Filed October 28, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 52/100
What the filing says
Encompass Health reported Q3 2026 net operating revenue of $1,609.5M (+8.9% YoY) and adjusted EBITDA of $346.6M (+15.5% YoY). The company raised full-year 2026 guidance: net operating revenue to $6,450–$6,500M (prior: $6,410–$6,490M), adjusted EBITDA to $1,395–$1,415M (prior: $1,365–$1,395M), and adjusted EPS to $6.23–$6.37 (prior: $6.02–$6.25). YTD 9M 2026, the company opened 4 hospitals (189 beds total), added 85 beds to existing hospitals, and repurchased 1.9M shares for $203.7M. Diluted share count is ~100M shares; net leverage stands at 1.8x.
Why this rating
Strong organic growth and margin expansion support raised guidance; modest relative to $12.2B market cap but meaningful operational inflection.
See more from October 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.